<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000334457"><TermName>edotecarin</TermName><TermPronunciation>(eh-doh-TEH-kar-in)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is a type of topoisomerase I inhibitor. Also called J-107088.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731793" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;edotecarin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731792" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;edotecarina&quot;" language="es" id="_4"/><SpanishTermName>edotecarina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor de la topoisomerasa. También se llama J-107088.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-09-24</DateFirstPublished><DateLastModified>2007-07-06</DateLastModified></GlossaryTerm>
